Gene Editing, Obesity Drugs And Long-Living Dogs: The Year In BiotechGene Editing, Obesity Drugs And Long-Living Dogs: The Year In Biotech - Forbes
forbes.comSubmitted by forbes3707 in health
2023 saw big shifts in the macroeconomics of the biotech sector, but also major technological milestones for longer, healthier lives.